Clinical Trials on Moderate to Severe Dry Eye Syndrome
Total 1642 results
-
Alcon ResearchCompletedModerate to Severe Dry Eye
-
Santen SASCompletedModerate to Severe Dry Eye SyndromeFrance
-
Wenzhou Medical UniversityCompletedEfficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye DiseaseModerate to Severe Dry Eye SyndromeChina
-
Meir Medical CenterUnknownHealthy Subjects | Moderate to Severe Keratoconjunctivitis Sicca (KCS) | Dry Eye Syndrome (DES)
-
Yonsei UniversityRecruitingModerate to Severe Dry EyeKorea, Republic of
-
University of Illinois at ChicagoJohnson & Johnson Vision Care, Inc.UnknownModerate to Severe Dry Eye DiseaseUnited States
-
John C Meyer, MDCompletedMild to Moderate Dry Eye DiseaseUnited States
-
Instituto Universitario de Oftalmobiología Aplicada...Completed
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical CorporationCompletedMild to Moderate Temporal Atrophy | Moderate to Severe Glabellar Rhytids | Moderate to Severe Periorbital RhytidsUnited States
-
Aqpha Medical B.V.Not yet recruitingModerate to Severe Nasolabial Fold
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Galderma R&DCompletedModerate to Severe Glabellar LinesChina
-
EuBiologics Co.,LtdCompletedModerate to Severe Glabellar LinesKorea, Republic of
-
AllerganCompletedModerate to Severe Nasolabial FoldsGermany, Netherlands
-
JHM BioPharma (Tonghua) Co. , Ltd.Recruiting
-
AbbVieCompletedModerate to Severe Glabellar LinesJapan
-
Chongqing Claruvis Pharmaceutical Co., Ltd.CompletedModerate to Severe Glabellar LinesChina
-
Croma-Pharma GmbHCompleted
-
AllerganCompletedModerate to Severe Nasolabial FoldsUnited States
-
IpsenCompletedModerate to Severe Glabellar LinesFrance, Germany
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate to Severe Glabellar LineKorea, Republic of
-
Merz North America, Inc.CompletedModerate to Severe Midface Volume DeficitCanada
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
Croma-Pharma GmbHActive, not recruitingModerate to Severe Midface Volume DeficitUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Nu Eyne Co., Ltd.RecruitingEarly to Moderate Dry Age-Related Macular DegenerationKorea, Republic of
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...TerminatedASD Accompanied by Moderate to Severe Gastrointestinal SymptomsChina
-
Astellas Pharma Europe Ltd.CompletedModerate to Severe Vasomotor SymptomsUnited Kingdom
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial Folds (NLFs)China
-
Merz North America, Inc.CompletedCorrection of the Moderate to Severe Nasolabial FoldsChina
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Santen SASCompletedDry Eye Disease With Severe KeratitisCzechia, France, Italy, Poland, Russian Federation, Spain, Turkey
-
Olympic Ophthalmics, Inc.RecruitingMicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye SyndromeUnited States
-
PfizerCompleted
-
Singapore National Eye CentreCompleted
-
Olympic Ophthalmics, Inc.RecruitingDry Eye SyndromesUnited States
-
Daewoong Bio Inc.CompletedDry Eye SyndromesKorea, Republic of
-
Kukje PharmaCompletedDry Eye SyndromesKorea, Republic of
-
University of WashingtonNational Eye Institute (NEI); National Institutes of Health (NIH)Completed
-
Medical University of ViennaCroma-Pharma GmbHCompleted
-
Innovative MedicalCompleted
-
SIFI SpACompleted
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
AllerganCompletedDry Eye SyndromesUnited States
-
Sight Sciences, Inc.Unknown
-
AllerganCompleted